This Article Full Text Full Text (PDF) All Versions of this Article: 26/1/41    most recent 01.ATV.0000193624.28251.83v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Monroe, D. M. Articles by Hoffman, M. Search for Related Content PubMed PubMed Citation Articles by Monroe, D. M. Articles by Hoffman, M. Related Collections Arterial thrombosis Deep vein thrombosis Coagulation Thrombin Regulation of Coagulation Coagulation and fibronolysis Platelets

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:41.)
© 2006 American Heart Association, Inc.

Brief Reviews

What Does It Take to Make the Perfect Clot?

Dougald M. Monroe; Maureane Hoffman

From the Pathology and Laboratory Medicine Service (M.H.), Durham Veterans Affairs Medical Center and Department of Pathology, Duke University Medical Center, Durham, and Carolina Cardiovascular Biology Center and Department of Medicine (D.M.M., M.H.), University of North Carolina, Chapel Hill, NC.

Correspondence to Maureane Hoffman, Pathology and Laboratory Medicine Service (113), Durham Veterans Affairs Medical Center, 508 Fulton St, Durham, NC 27705. E-mail maureane.hoffman{at}med.va.gov

Series Editor: Yale Nemerson
ATVB In Focus Regulation of Coagulation

Previous Brief Review in this Series:

•Jesty J, Beltrami E. Positive feedbacks of coagulation: their role in threshold regulation. 2005;25:2463–2469.

The coagulation process has been conceptualized as being primarily dependent on adequate levels of the coagulation proteins. This concept was based on the clear relationship between the bleeding tendency and factor levels in hemophilia. The field is now evolving toward conceptualizing coagulation as being actively regulated by the specialized cellular components of the process. Rather than conceiving coagulation as only a "cascade" of proteolytic reactions, the coagulation reactions occur as overlapping steps on cell surfaces. Components of the old "extrinsic’" and "intrinsic" pathways of coagulation can be thought of as participating in the initiation and propagation of coagulation reactions, respectively. Thus, these pathways are not redundant as they are portrayed in the cascade model, but play distinct and complementary roles. Our understanding of how specific cellular features control the processes of hemostasis and thrombosis is developing rapidly. This review discusses some aspects of the cellular control of coagulation.

The coagulation process has been conceptualized as being primarily dependent on adequate levels of the coagulation proteins. This concept was based on the clear relationship between the bleeding tendency and factor levels in hemophilia. Our understanding of how specific cellular features control the processes of hemostasis and thrombosis is developing rapidly. This review discusses some aspects of the cellular control of coagulation.

Key Words: hemostasis • partial thromboplastin time • platelets • prothrombin time • tissue factor

This article has been cited by other articles:

				B. L. Henry, J. Connell, A. Liang, C. Krishnasamy, and U. R. Desai Interaction of Antithrombin with Sulfated, Low Molecular Weight Lignins: OPPORTUNITIES FOR POTENT, SELECTIVE MODULATION OF ANTITHROMBIN FUNCTION J. Biol. Chem., July 31, 2009; 284(31): 20897 - 20908. [Abstract] [Full Text] [PDF]

				R. Gill, M. Herbertson, A. Vuylsteke, P. S. Olsen, C. von Heymann, M. Mythen, F. Sellke, F. Booth, and T. A. Schmidt Safety and Efficacy of Recombinant Activated Factor VII: A Randomized Placebo-Controlled Trial in the Setting of Bleeding After Cardiac Surgery Circulation, July 7, 2009; 120(1): 21 - 27. [Abstract] [Full Text] [PDF]

				F. Semeraro, C. T. Ammollo, N. Semeraro, and M. Colucci Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins Haematologica, June 1, 2009; 94(6): 819 - 826. [Abstract] [Full Text] [PDF]

				G. Romney and M. Glick An Updated Concept of Coagulation With Clinical Implications J Am Dent Assoc, May 1, 2009; 140(5): 567 - 574. [Abstract] [Full Text] [PDF]

				M. Y. Chan, F. Andreotti, and R. C. Becker Hypercoagulable States in Cardiovascular Disease Circulation, November 25, 2008; 118(22): 2286 - 2297. [Full Text] [PDF]

				B. Dahlback Advances in understanding pathogenic mechanisms of thrombophilic disorders Blood, July 1, 2008; 112(1): 19 - 27. [Abstract] [Full Text] [PDF]

				M. Mittermayr, W. Streif, T. Haas, D. Fries, C. Velik-Salchner, A. Klingler, E. Oswald, C. Bach, M. Schnapka-Koepf, and P. Innerhofer Hemostatic Changes After Crystalloid or Colloid Fluid Administration During Major Orthopedic Surgery: The Role of Fibrinogen Administration Anesth. Analg., October 1, 2007; 105(4): 905 - 917. [Abstract] [Full Text] [PDF]

				Y. Ramot and A. Nyska Drug-Induced Thrombosis--Experimental, Clinical, and Mechanistic Considerations Toxicol Pathol, February 1, 2007; 35(2): 208 - 225. [Abstract] [Full Text] [PDF]

				K. W. Mahaffey and R. C. Becker The Scientific Community's Quest to Identify Optimal Targets for Anticoagulant Pharmacotherapy Circulation, November 28, 2006; 114(22): 2313 - 2316. [Full Text] [PDF]

				M. Hoffman, A. Harger, A. Lenkowski, U. Hedner, H. R. Roberts, and D. M. Monroe Cutaneous wound healing is impaired in hemophilia B Blood, November 1, 2006; 108(9): 3053 - 3060. [Abstract] [Full Text] [PDF]

				P. Porschewski, M. A.-M. Grattinger, K. Klenzke, A. Erpenbach, M. R. Blind, and F. Schafer Using Aptamers as Capture Reagents in Bead-Based Assay Systems for Diagnostics and Hit Identification J Biomol Screen, October 1, 2006; 11(7): 773 - 781. [Abstract] [PDF]